Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings

Madrigal Pharmaceuticals (NASDAQ: MDGL ) has been on my radar for some time due to its lead candidate Rezdiffra. However, I've held off from initiating a position up until now, primarily due to concerns about the company's overvaluation. It felt as if He is the leader of the investing group Compounding Healthcare . Features of the group include: Several model healthcare portfolios, a weekly newsletter, a daily watchlist, and chat for dialogue and questions. Learn more Biologics is a full-time healthcare inv ...